The event was held as part of the All-Russian Congress of patients.

The discussion was devoted to the issues related to the decline in birth rates. Reproductive health moves to the forefront when we are taking appropriate measures to ensure the growth of the Russian population and demographic stability.

Speakers of the round table discussion dwelled on the demographic situation, measures of support taken at the government level to help quickly and consistently eliminate bottlenecks, on things that hinder the improvement of the people’s reproductive health.

The following experts were invited to participate in the event: Natalia Sergeevna Solovyova (Chairman of the Association of Individuals Suffering from Infertility), Igor Yurievich Kogan (Director of the D. O. Ott Scientific and Research Institute of Obstetrics, Gynecology and Reproductology, corresponding member of RAS (Russian Academy of Sciences), professor at the Department of obstetrics, gynecology and reproductive science of the St. Petersburg State University, MD), Tatiana Viktorovna Buckaya (expert at ONF (All-Russia People’s Front), Chairman of the Board of Mothers of Russia, President of the Association of Consumers and Producers of Children’s Goods and Services “Choice of Parents”), Mikhail Sergeevich Nekrasov (General Director, Chairman of the Board of NANOLEK LLC) and other experts.

The discussion was moderated by: Oleg Ivanovich Apolikhin (Chief freelance expert on reproductive health of the Ministry of Health of the Russian Federation, Director of the N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology, a branch of the FSBI “SMRC of radiology” of the Ministry of Health of Russia, MD, professor, corresponding member of the Russian Academy of Sciences), Kirill Viktorovich Litovchenko (Head of the Think Tank on Demographic Policy and Reproductive Health of the All-Russian Public Organization “Delovaya Rossiya”, General Director of Ferring Pharmaceuticals LLC).

Mikhail Nekrasov mentioned in his report that cervical cancer is the only oncological disease that can be prevented by way of primary prevention - an HPV vaccine, according to the World Health Organization. 91 countries have included this vaccine in their national vaccination schedules.

Cervical cancer (CC) was found to be caused by HPV 16 and 18 in 66.2% of cases, according to independent scientific publications. In Russia, the incidence of cervical cancer has increased by 25.81% since 2007. As the patients are young women, this certainly results in the socio-demographic damages and loss of reproductive capacity.

“This topic is also very important for achieving the targets as part of the “Healthcare” national project which focuses on increasing the life expectancy of citizens. Cancer is the second leading cause of death globally, according to the statistics, so we need to fight this challenge.

NANOLEK joined forces with Kombiotech to develop an entirely domestic 4-valent vaccine against HPV (human papillomavirus) of 4 types (6, 11, 16, 18), which causes cervical cancer. Mikhail Sergeyevich explained that research on this vaccine will be launched in the near future, registration will follow in 2023.”

The All-Russian Congress of Patients is held annually by the All-Russian Union of Patients which is supported by the Ministry of Health of the Russian Federation, the Federal Service for Supervision of Healthcare, and federal authorities.